Profile data is unavailable for this security.
About the company
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
- Revenue in HKD (TTM)648.60bn
- Net income in HKD9.51bn
- Incorporated2003
- Employees113.64k
- LocationSinopharm Group Co LtdSinopharm Group Building, No. 385, EastSHANGHAI 200023ChinaCHN
- Phone+86 2 123052666
- Fax+86 2 123052888
- Websitehttps://www.sinopharmgroup.com.cn/
| Holder | Shares | % Held |
|---|---|---|
| Lazard Asset Management LLCas of 31 Jul 2024 | 109.19m | 8.14% |
| Fidelity Management & Research Co. LLCas of 02 Apr 2024 | 102.00m | 7.60% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Jul 2024 | 52.84m | 3.94% |
| The Vanguard Group, Inc.as of 08 Aug 2024 | 49.07m | 3.66% |
| Dimensional Fund Advisors LPas of 08 Aug 2024 | 27.08m | 2.02% |
| BlackRock Fund Advisorsas of 02 Aug 2024 | 24.32m | 1.81% |
| Value Partners Ltd.as of 31 Dec 2023 | 22.93m | 1.71% |
| FIAM LLCas of 02 Apr 2024 | 22.91m | 1.71% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 21.52m | 1.60% |
| Fidelity Investments Canada ULCas of 30 Jun 2024 | 20.84m | 1.55% |
